McBarron Paul - Insider Non-Derivative Transactions at Cyclacel Pharmaceuticals, Inc. (CYCC) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Dec 21, 2023, McBarron Paul's relationship to Cyclacel Pharmaceuticals, Inc. (CYCC) is Director,Officer (See Remarks), and currently has 33,378 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CYCC insiders.
Data Source: SEC.
McBarron Paul - Insider Non-Derivative Transactions of CYCC Common Stock
McBarron Paul - Insider Non-Derivative Transactions at CYCC
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Dec 22, 2023 | P -- (Common Stock) | 1886 | 3.32 | 33378 |
| Feb 1, 2023 | Acquisition -- (Common Stock) | 31200 | 0 | 31492 |